*  Proteus Infections in a General Hospital. I. Biochemical Characteristics and Antibiotic Susceptibility of the OrganismsWith...
Proteus Infections in a General Hospital. II. Some Clinical and Epidemiological Characteristics: With an Analysis of 71 Cases ... Proteus Infections in a General Hospital. I. Biochemical Characteristics and Antibiotic Susceptibility of the Organisms: With ... Proteus Infections in a General Hospital. I. Biochemical Characteristics and Antibiotic Susceptibility of the Organisms: With ... Carbenicillin and gentamicin were equally active against P. mirabilis and against indole-positive strains of Proteus. ...
*  A Study of Proteus Infections in a Male Urological Ward | Journal of Clinical Pathology
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center's RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.. ...
*  British Library EThOS: Dendron-based synthetic bacteriophages for the treatment of Proteus mirabilis infections
The Proteus mirabilis bacteria were focused on in this study as they are significant biofilm formers in chronic infections such ... Dendron-based synthetic bacteriophages for the treatment of Proteus mirabilis infections Author: Aniejurengho, Orode Uche ... Firstly, novel bacteriophages against clinical strains of Proteus mirabilis were isolated with physicochemical and genomic ... The National Institute of Health reports that 80 % of human infections are biofilm related. ...
*  Proteus Vulgaris - Hospital Acquired Infections | Pearltrees
Description Proteus vulgaris (P. vulgaris) is widespread in nature, mainly found in flora of human gastrointestinal tract. The ... Proteus Vulgaris Genotyping Analysis Proteus vulgaris (P. vulgaris) is widespread in nature, mainly found in flora of human ... Description Proteus vulgaris (P. vulgaris) is widespread in nature, mainly found in flora of human gastrointestinal tract. The ... Alteration in P. vulgaris' Characteristics Title: Phenotyping and Genotyping Characterization of Proteus vulgaris After ...
*  How Is Ciprofloxacin Used? | Diseases Treated by Ciprofloxacin
Proteus Infections 20 Pseudomonas infection 21 Sinusitis Nausea, Nasal congestion, Fever 22 Staphylococcal infection ... Urinary tract infection Urethritis, Urinary urgency, Dysuria Filed Under: Diseases / Medical Conditions ScienceDiseases prev ...
*  Gram-negative septicemia caused by providencia stuartii.
Proteus Infections* / drug therapy. Providencia. Sepsis / drug therapy, etiology*. Shock, Septic / drug therapy, etiology. ... 1085924 - Epiglottitis: incidence of extraepiglottic infection: report of 72 cases and review of .... ...
*  Renal Flashcards by Imaan Ansari | Brainscape
especially aw/ Proteus infection. - Tumor-like growth, upper urinary tract infection, and lipid-laden foamy macrophages (make ... Few weeks after GAS infection (of skin or pharynx). - Increased anti-DNase B. - cola colored urine and facial edema. ... Chronic infection is associated with an increased risk of squamous cell carcinoma of the bladder ... Children after recent infection. - aw/ Hodgkins. - Great response to steroids. - Selective albuminuria ...
*  Subvisual Subway - Bacteria of the New York City subway on Behance
Proteus vulgaris. Small blue / green colonies. Found in soil, water, fecal matter - causes wound infections, urinary tract ...
*  didkata</strong> - ?? </span><i class="user...
Infections associated with Proteus sp.. Urinary Tract InfectionsThe most common infection associated with this genus is urinary ... Proteus spp. can cause primary urinary tract infections and secondary infections. Naturally occur in the intestines of humans ... Proteus mirabilisurinary tract infection in an elderly person at home. In Infections andNursing Practice Prevention and Control ... SpeciesKingdoms/0Genera_M_Gracilicutes/Proteus/Proteus.htm. ?? Other studies show the reduction or absence of putrefactive ...
*  Proteus vulgaris - Wikipedia
Nosocomial infections P. mirabilis causes 90% of Proteus infections. P. vulgaris and P. penneri are easily isolated from ... and those whose infections were acquired in the hospital have an increased frequency of infection caused by Proteus and other ... The term Proteus signifies changeability of form, as personified in the Homeric poems in Proteus, "the old man of the sea", who ... It is known to cause wound infections and other species of its genera are known to cause urinary tract infections. ...
*  Enterobacteriaceae - ONA
Proteus. *. P. mirabilis causes 90% of infections, which are acquired in the community, LTCF, and hospital. P. vulgaris and P. ... Proteus, Morganella, and Providencia: UTI can result in the development of "infection stones" and, if untreated (both the ... Proteus UTI can be complicated by infection stones, and stone removal is requisite for cure. ... What host factors protect against this infection? * What are the clinical manifestations of infection with this organism? * ...
*  For practitioners - All Things Vagina
Proteus infection - a cause of UTIs. Proteus infection ranges from a simple UTI to sepsis, and requires immediate, thorough ... Pseudomonas aeruginosa infections in women - a cause of UTI. P. aeruginosa is a common cause of urinary tract infections and ... Why you get a vaginal yeast infection after antibiotics. How to deal with an antibiotic-driven yeast infection. ... Study: do circumcised penises mean less vaginal infections? (spoiler alert - yes). Circumcised penises result in less infection ...
*  Proteus mirabilis - Wikipedia
"Proteus Infections Medication". Medscape. Retrieved 30 October 2015. Proteus Genome Projects from Genomes OnLine Database Type ... Proteus species can also cause wound infections, septicemia, and pneumonia, mostly in hospitalized patients. P. mirabilis is ... P. mirabilis causes 90% of all Proteus infections in humans. It is widely distributed in soil and water. An alkaline urine ... In humans, Proteus is found as part of the normal flora of the gut....from BioMedHTC Proteus mirabilis and Urinary Tract ...
*  Alternative treatments for proteus mirabilis - Things You Didn't Know
Is amoxcillin a good treatment for proteus mirabilis? Proteus mirabilis. I am assuming you have UTI with this organism. If so, ... Common: Proteus mirabilis is often found as a cause of urinary tract infection. Because the bug produces a urease enzyme, the ... Proteus mirabilis: This is a potential cause of urinary tract infection, or if you have spillage of fecal contents into the ... Not typical: Proteus mirabilis is not a typical pathogen of vaginal infections. It is more typical of uti's, but you probably ...
*  Microscopic colitis and biopsy results - Crohn's Disease Forum - Support group and forum for Crohn's Disease, Ulcerative...
A stool test was basically clear apart from a possible Proteus infection and low n-butyrate.. Sorry for the long story but what ...
PROTEUS. Zie ook: BACTERI N BACTERIA. Zie ook: PROTEUS INFECTIE PROTEUS INFECTIONS. Zie ook: PROTEUS SYNDROOM PROTEUS-like ... MerckManual: Proteus (Infectie) PROTEUS INFECTIE PROTEUS INFECTIONS. Zie ook: ENTEROBACTERIACEAE INFECTIONS. Zie ook: PROTEUS. ... Proteus-syndroom *Proteus Syndroom *Proteus Syndrome Foundation *eMedicine: Proteus Syndrome *Proteus Syndrome *Proteus ... MerckManual: Proteus (Infectie) PROTEUS SYNDROOM PROTEUS-like SYNDROOM PROTEUS SYNDROME. Zie ook: PROTEUS. Zie ook: ...
*  Lithostat (Acetohydroxamic Acid Tablets): Side Effects, Interactions, Warning, Dosage & Uses
... allowed successful antibiotic treatment of urea-splitting Proteus infections after surgical removal of struvite stones in ... However, if infection persists or if a small stone fragment persists, then there is an increased risk of stone recurrence. ... It has been known for many years that urinary infection may cause the formation of urinary stones. As these stones form, ... If a metabolic stone becomes infected, then an "infection stone" may grow onto the "metabolic stone." Stone analysis and/or ...
*  Hyperlipid: 01/01/2009 - 02/01/2009
My understanding of RA is based around Prof Ebringer's work, summarised here, linking urinary proteus infection to antibody ... So to summarise: A combination of metabolic syndrome with Proteus mirabilis infection is a generator of struvite stones. The ... They have to have recurrent or continuous low grade urinary tract proteus infection, probably without signs and probably ... Here it was the subgroup which lowered both faecal proteus count and blood anti proteus IgG count which improved. They didn't ...
*  Hyperlipid: Rheumatoid arthritis and kidney stones
My understanding of RA is based around Prof Ebringer's work, summarised here, linking urinary proteus infection to antibody ... So to summarise: A combination of metabolic syndrome with Proteus mirabilis infection is a generator of struvite stones. The ... They have to have recurrent or continuous low grade urinary tract proteus infection, probably without signs and probably ... Here it was the subgroup which lowered both faecal proteus count and blood anti proteus IgG count which improved. They didn't ...
*  Cephalosporins - Patent # 5621095 - PatentGenius
The composition can also be used as medicaments in the treatment of colibacilloses and associated infections,proteus infection ... The novel method of the invention for combatting bacterial infections in warm-blooded animals, including humans, comprises ... Their effectiveness on gram (-) bacteria, notably on coliform bacteria,klebsiella, salmonella, proteus and pseudomonas, is ... object of the invention to provide novel anti-bacterial compositions and a novel method of combatting bacterial infections in ...
*  Phenotypic and Molecular Characterization of Plasmid Mediated AmpC β-Lactamases among Escherichia coli, Klebsiella spp., and...
... and Proteus mirabilis Isolated from Urinary Tract Infections in Egyptian Hospitals. Mai M. Helmy1,2 and Reham Wasfi2 ... and Proteus mirabilis Isolated from Urinary Tract Infections in Egyptian Hospitals," BioMed Research International, vol. 2014, ...
*  Phenotypic and Molecular Characterization of Plasmid Mediated AmpC β-Lactamases among Escherichia coli, Klebsiella spp., and...
and Proteus mirabilis in a regional clinical microbiology laboratory," Clinical Microbiology and Infection, vol. 16, no. 2, pp ... and Proteus mirabilis Isolated from Urinary Tract Infections in Egyptian Hospitals. Mai M. Helmy1,2 and Reham Wasfi2 ... Y. S. Park, S. Yoo, M.-R. Seo, J. Y. Kim, Y. K. Cho, and H. Pai, "Risk factors and clinical features of infections caused by ... H. Pai, C.-I. Kang, J.-H. Byeon et al., "Epidemiology and clinical features of bloodstream infections caused by AmpC-type-β- ...
*  Escherichia - Wikipedia
ISBN 0-9631172-1-1. (via NCBI Bookshelf). Ronald A (2003). "The etiology of urinary tract infection: traditional and emerging ... Escherichia, Klebsiella, Enterobacter, Serratia, Citrobacter, and Proteus. In: Baron's Medical Microbiology (4th ed.). Univ of ... and are known as the most common cause of urinary tract infections, significant sources of gastrointestinal disease, ranging ...

(1/238) Identification of protease and rpoN-associated genes of uropathogenic Proteus mirabilis by negative selection in a mouse model of ascending urinary tract infection.

Proteus mirabilis, a motile gram-negative bacterium, is a principal cause of urinary tract infections in patients with functional or anatomical abnormalities of the urinary tract or those with urinary catheters in place. Thus far, virulence factors including urease, flagella, haemolysin, various fimbriae, IgA protease and a deaminase have been characterized based on the phenotypic traits conferred by these proteins. In this study, an attempt was made to identify new virulence genes of P. mirabilis that may not have identifiable phenotypes using the recently described technique of signature-tagged mutagenesis. A pool of chromosomal transposon mutants was made through conjugation and kanamycin/tetracycline selection; random insertion was confirmed by Southern blotting of chromosomal DNA isolated from 16 mutants using the aphA gene as a probe. From the total pool, 2.3% (9/397) auxotrophic mutants and 3.5% (14/397) swarming mutants were identified by screening on minimal salts agar and Luria agar plates, respectively. Thirty per cent of the mutants, found to have either no tag or an unamplifiable tag, were removed from the input pool. Then 10(7) c.f.u. from a 96-mutant pool (approximately 10(5) c.f.u. of each mutant) were used as an input pool to transurethrally inoculate seven CBA mice. After 2 d infection, bacteria were recovered from the bladders and kidneys and yielded about 10(5) c.f.u. as an output pool. Dot blot analysis showed that two of the 96 mutants, designated B2 and B5, could not be hybridized by signature tags amplified from the bladder output pool. Interrupted genes from these two mutants were cloned and sequenced. The interrupted gene in B2 predicts a polypeptide of 37.3 kDa that shares amino acid similarity with a putative protease or collagenase precursor. The gene in B5 predicts a polypeptide of 32.6 kDa that is very similar to that encoded by ORF284 of the rpoN operon controlling expression of nitrogen-regulated genes from several bacterial species. The virulence of the two mutants was tested further by co-challenging CBA mice with each mutant and the parental strain. After 1 week of infection, the B2 and B5 mutants were recovered in numbers 100-fold and 1000-fold less than the parental strain, respectively. Using an in vitro assay, it was shown that the B2 mutant had significantly less (P = 0.0001) extracellular protease activity than the wild-type strain. These findings demonstrate that signature-tagged mutagenesis is a viable approach to identify bacterial genes associated with the ability to infect the urinary tract.  (+info)

(2/238) Requirement of MrpH for mannose-resistant Proteus-like fimbria-mediated hemagglutination by Proteus mirabilis.

Two new genes, mrpH and mrpJ, were identified downstream of mrpG in the mrp gene cluster encoding mannose-resistant Proteus-like (MR/P) fimbriae of uropathogenic Proteus mirabilis. Since the predicted MrpH has 30% amino acid sequence identity to PapG, the Galalpha(1-4)Gal-binding adhesin of Escherichia coli P fimbriae, we hypothesized that mrpH encodes the functional MR/P hemagglutinin. MR/P fimbriae, expressed in E. coli DH5alpha, conferred on bacteria both the ability to cause mannose-resistant hemagglutination and the ability to aggregate to form pellicles on the broth surface. Both a DeltamrpH mutant expressed in E. coli DH5alpha and an isogenic mrpH::aphA mutant of P. mirabilis were unable to produce normal MR/P fimbriae efficiently, suggesting that MrpH was involved in fimbrial assembly. Amino acid residue substitution of the N-terminal cysteine residues (C66S and C128S) of MrpH abolished the receptor-binding activity (hemagglutinating ability) of MrpH but allowed normal fimbrial assembly, supporting the notion that MrpH was the functional MR/P hemagglutinin. Immunogold electron microscopy of P. mirabilis HI4320 revealed that MrpH was located at the tip of MR/P fimbriae, also consistent with its role in receptor binding. The isogenic mrpH::aphA mutant of HI4320 was less able to colonize the urine, bladder, and kidneys in a mouse model of ascending urinary tract infection (P < 0.01), and therefore MR/P fimbriae contribute significantly to bacterial colonization in mice. While there are similarities between P. mirabilis MR/P and E. coli P fimbriae, there are more notable differences: (i) synthesis of the MrpH adhesin is required to initiate fimbrial assembly, (ii) MR/P fimbriae confer an aggregation phenotype, (iii) site-directed mutation of specific residues can abolish receptor binding but allows fimbrial assembly, and (iv) mutation of the adhesin gene abolishes virulence in a mouse model of ascending urinary tract infection.  (+info)

(3/238) Growth, cellular differentiation and virulence factor expression by Proteus mirabilis in vitro and in vivo.

A uropathogenic strain of Proteus mirabilis was grown in vitro in human and mouse urine and brain-heart infusion broth (BHIB) and in vivo in subcutaneous open chambers (SOC) in mice, intraperitoneal diffusion chambers (IPC) in rats and by ascending urinary tract infection in mice in order to compare growth pattern, cellular differentiation and expression of virulence factors. Although the growth rate was slower in vivo than in vitro, the extent of growth was similar after 24 h. PR mirabilis differentiated into filamentous swarmer cells in all in-vitro culture conditions, but no filamentous cells were observed in either of the in-vivo chamber models. Transurethrally infected mice showed a rapid release or loss of filamentous cells and these could not be seen in kidney or bladder homogenates 7 days after infection. Bacteria showed increasing haemagglutination titres for fresh and tanned red blood cells after subculturing in BHIB, but bacteria grown in vivo did not show haemagglutination. An increasing resistance to normal serum was found when bacteria were grown in vivo. Significant haemolytic activity was detected with bacteria grown in BHIB and IPC, but almost no activity was found when bacteria had grown in urine. These findings improve the understanding of the role of P. mirabilis uropathogenic virulence factors in vivo.  (+info)

(4/238) Investigation of the types and characteristics of the proteolytic enzymes formed by diverse strains of Proteus species.

Many diverse clinical isolates of Proteus mirabilis (48 strains), P. penneri (25), P. vulgaris biogroup 2 (48) and P. vulgaris biogroup 3 (21) from man were examined for their ability to produce proteolytic enzymes and the nature and characteristics of the proteases were studied. All the P. penneri isolates, most (94-90%) of the P. mirabilis and P. vulgaris biogroup 2 isolates, but only 71% of the P. vulgaris biogroup 3 isolates, secreted proteolytic enzymes. These were detected most readily at pH 8 with gelatin as substrate. A strong correlation was found between the ability of a strain to form swarming growth and its ability to secrete proteases. Non-swarming isolates invariably appeared to be non-proteolytic. However, some isolates, particularly of P. vulgaris biogroup 3, were non-proteolytic even when they formed swarming growth. Analysis of the secreted enzymes of the different Proteus spp. on polyacrylamide-gelatin gels under various constraints of pH and other factors showed that they were all EDTA-sensitive metalloproteinases. Analysis of the kinetics of production of the proteases revealed the formation of an additional protease of undefined type and function that was cell-associated and formed before the others were secreted. The secreted protease was subsequently modified to two isoforms whose mass (53-46 kDa) varied with the Proteus spp. and the strain. There was no evidence that the secreted proteases of strains of Proteus spp. were of types other than metalloproteinases.  (+info)

(5/238) Structures of the O-specific polysaccharides and a serological cross-reactivity of the lipopolysaccharides of Proteus mirabilis O24 and O29.

Strains of Proteus mirabilis belonging to serogroups O24 and O29 are frequent in clinical specimens. Anti-P. mirabilis O24 serum cross-reacted with the lipopolysaccharide (LPS) of P. mirabilis O29 and vice versa. The structures of the O-specific polysaccharides (OPSs, O-antigens) of both LPSs were established using sugar analysis and one- and two-dimensional 1H- and 13C-NMR spectroscopy and found to be different. SDS-PAGE and Western immunoblotting suggested that the serological cross-reactivity of the LPSs is due to a common epitope(s) on the core-lipid A moiety, rather than on the OPS. Therefore, the epitope specificity and the structures of the O-antigens studied are unique among Proteus serogroups.  (+info)

(6/238) Serum immunoglobulin response and protection from homologous challenge by Proteus mirabilis in a mouse model of ascending urinary tract infection.

We tested the hypothesis that experimental Proteus mirabilis urinary tract infection in mice would protect against homologous bladder rechallenge. Despite production of serum immunoglobulin G (IgG) and IgM (median titers of 1:320 and 1:80, respectively), vaccinated (infected and antibiotic-cured) mice did not show a decrease in mortality upon rechallenge; the survivors experienced only modest protection from infection (mean log(10) number of CFU of P. mirabilis Nal(r) HI4320 per milliliter or gram in vaccinated mice versus sham-vaccinated mice: urine, 100-fold less [3.5 versus 5.5; P = 0.13]; bladder, 100-fold less [3.1 versus 5.1; P = 0.066]; kidneys, 40-fold less [2.7 versus 4.3; P = 0.016]). Western blots using protein from the wild-type strain and isogenic mutants demonstrated antibody responses to MR/P and PMF fimbriae and flagella. There was no correlation between serum IgG or IgM levels and protection from mortality or infection. There was a trend toward elevated serum IgA titers and protection from subsequent challenge (P >/= 0.09), although only a few mice developed significant serum IgA levels. We conclude that prior infection with P. mirabilis does not protect significantly against homologous challenge.  (+info)

(7/238) Problems related to determination of MICs of oximino-type expanded-spectrum cephems for Proteus vulgaris.

During in vitro susceptibility testing of clinical isolates of Proteus vulgaris, we noted that the MICs of several expanded-spectrum cephems were much higher in the broth microdilution method than in the agar dilution method (termed the MIC gap phenomenon). Here we investigated the mechanism of the MIC gap phenomenon. Cephems with the MIC gap phenomenon were of the oximino type, such as cefotaxime, cefteram, and cefpodoxime, which serve as good substrates for inducible class A beta-lactamase (CumA) enzymes produced by P. vulgaris; this finding suggests a relationship between the MIC gap phenomenon and CumA. Since peptidoglycan recycling shares a system common to that inducing CumA, we analyzed the mechanism of the MIC gap phenomenon using P. vulgaris B317 and isogenic mutants with mutations in the peptidoglycan recycling and beta-lactamase induction systems. The MIC gap phenomenon was observed in the parent strain B317 but not in B317G (cumG-defective mutant; defective peptidoglycan recycling) and B317R (cumR-defective mutant; defective CumA transcriptional regulator). No beta-lactamase activity was detected in B317G and B317R. beta-Lactamase activity and the MIC gap phenomenon were restored in B317G/pMD301 (strain transcomplemented by a cloned cumG gene) and B317R/pMD501 (strain transcomplemented by a cloned cumR gene). MICs determined by the agar dilution method increased when lower agar concentrations were used. Our results indicated that the mechanism of the MIC gap phenomenon is related to peptidoglycan recycling and CumA induction systems. However, it remains unclear how beta-lactamase induction of P. vulgaris is suppressed on agar plates.  (+info)

(8/238) Evaluation of the discriminatory powers of the Dienes test and ribotyping as typing methods for Proteus mirabilis.

A total of 63 clinical isolates of Proteus mirabilis collected over a 19-month period were typed by the Dienes test and ribotyping. Ribotyping was performed using the fully automated RiboPrinter Microbial Characterization System (Qualicon, Wilmington, Del.). Isolates that were indistinguishable by the Dienes test and/or ribotyping were characterized further by pulsed-field gel electrophoresis (PFGE). Most of the isolates represented unique strains as judged by the Dienes test and ribotyping. Forty isolates represented 40 different ribotypes and Dienes types. The remaining 23 isolates were grouped into 13 Dienes types, 12 ribotypes, and 14 PFGE types. The index of discrimination was 0.980 for the Dienes test, 0.979 for ribotyping, and 0.992 for PFGE. Both the Dienes test and ribotyping are useful methods for identifying individual strains of P. mirabilis. The Dienes test is simple, inexpensive, and easy to perform. It can be performed in virtually any laboratory and should be used in the initial epidemiologic characterization of P. mirabilis isolates.  (+info)

  • antibiotics
  • The results also provide a promising antimicrobial strategy for use of dendrons as therapeutic agents, alone or in combination with antibiotics and bacteriophages for treatment of biofilm-related infections. (bl.uk)
  • Why doesn't a short course of antibiotics clear up both the urinary proteus and the RA? (blogspot.com)
  • It is also essentially impossible to eliminate all proteus from the gut using antibiotics, provided the gut environment is convivial to the microbe. (blogspot.com)
  • Treatment of M. morganii infections may include: Ticarcillin Piperacillin Ciprofloxacin Third-generation and fourth-generation cephalosporins A study conducted at the University Hospital at Heraklion, Crete, Greece showed a 92% success rate in the use of these antibiotics. (wikipedia.org)
  • In the developed world it is often only used for two days until bacterial cultures determine what antibiotics the infection is sensitive to. (wikipedia.org)
  • isolates
  • TreatmentMost isolates of Proteus are susceptible to all commonly employed antimicro-bial drugs with the exception of tetracycline. (bg-mamma.com)
  • organisms
  • The first use of the term "Proteus" in bacteriological nomenclature was made by Hauser (1885), who described under this term three types of organisms which he isolated from putrefied meat. (wikipedia.org)
  • Patients with recurrent infections, those with structural abnormalities of the urinary tract, those who have had urethral instrumentation, and those whose infections were acquired in the hospital have an increased frequency of infection caused by Proteus and other organisms (e.g. (wikipedia.org)
  • Exogenous infections can be caused by organisms that colonize the skin such as Staphylococcus aureus or Streptococcus spp. (wikipedia.org)
  • Gentamicin is not used for Neisseria gonorrhoeae, Neisseria meningitidis or Legionella pneumophila bacterial infections (because of the risk of the person going into shock from lipid A endotoxin found in certain Gram-negative organisms). (wikipedia.org)
  • Staphylococcus
  • Indications for sultamicillin include: Skin and soft tissue infections - furuncles, carbuncles, cellulitis, paronychia, impetigo contagiosa, diabetic foot ulcers and abscesses caused by Staphylococcus aureus and Streptococcus pyogenes. (wikipedia.org)
  • Lower respiratory tract infections - bacterial pneumonias, bronchitis, bronchiectasis caused by S. pneumoniae, H. influenzae, Staphylococcus aureus and S. progenies. (wikipedia.org)
  • Clinical
  • They don't go away unless you sort out the metabolic syndrome as well as the urinary infection, which is often sub clinical and the person carrying it doesn't even know they have it. (blogspot.com)
  • widely distributed
  • Proteus bacilli are widely distributed in nature as saprophytes, being found in decomposing animal matter, sewage, manure soil, the mammalian intestine, and human and animal feces. (wikipedia.org)
  • anaerobic
  • Exposure to higher doses of radiation is associated with systemic anaerobic infections due to gram negative bacilli and gram positive cocci. (wikipedia.org)
  • Nasal
  • Autoimmune factors: viral infection or some other unidentified insult may trigger antigenicity of the nasal mucosa. (wikipedia.org)
  • recurrent
  • This is usually done in the case of recurrent infection or because of the presence of an anal sac adenocarcinoma, a malignant tumor. (wikipedia.org)
  • kidney stones
  • If this happens in the urine due to infection it can result in kidney stones . (healthtap.com)
  • I just wanted to tidy up some loose ends I have in my head about rheumatoid arthritis, diet, kidney infections and kidney stones before I can get on to other ideas. (blogspot.com)
  • Neutropenia
  • There is a direct quantitative relationship between the magnitude of the neutropenia that develops after exposure to radiation and the increased risk of developing infection. (wikipedia.org)
  • antibiotic
  • In the last two decades a surge in antibiotic resistance has limited antibiotic effectiveness increasing the risk of uncontrolled epidemics especially for biofilm-related infections. (bl.uk)
  • How to deal with an antibiotic-driven yeast infection. (allthingsvagina.com)
  • So antibiotic therapy tends to be limited in effect as it is difficult to clear the urinary infection in the presence of struvite stone(s) and difficult to dissolve the stones in the presence of metabolic syndrome. (blogspot.com)
  • Occasionally treatment may include, lancing of an abscess or antibiotic infusion into the gland in the case of infection. (wikipedia.org)
  • Gentamicin, sold under brand names Garamycin among others, is an antibiotic used to treat several types of bacterial infections. (wikipedia.org)
  • therapeutic
  • Towards investigating the development of new antimicrobial strategies, the aims of this thesis were to assess: (i) the therapeutic potential of bacteriophages against Proteus mirabilis biofilms and (ii) the development of a novel antimicrobial strategy based on a synthetic biology approach for improvement of bacteriophage-based biofilm control. (bl.uk)